Home

Biotechnology Value Fund reported a 5.2% stake in Protagonist Therapeutics PTGX · 3,211,041 sh · passive holder

Trade details

Type
5% stake report
Report
13G passive
Stake
5.2%
Last report
First report
Shares held
3,211,041 sh
Class
Common Stock, $0.00001 par value per share
Event date
25/06/09
Filed
25/06/16

First 5%+ report · 5.2% stake

Protagonist Therapeutics trades, last 26 weeks

What else happened in Protagonist Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/10~25/07/09

Biotechnology Value Fund's other 5% stake reports